Morning Read: Abbott pays $225M for heart valve replacement developer Tendyne, NuVasive coughs up $13.5M for false Medicare claim allegations
Abbott Laboratories is paying $225M for the heart valve replacement developer Tendyne, and NuVasive is spending $13.5M in order to settle after false Medicare claim allegations.